Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer's disease

Neuroscience Letters

Volumn 367, Issue 3, 2004, Pages 379-383

  Nacmias, Benedetta ^a   Piccini, Carolina ^a   Bagnoli, Silvia ^a   Tedde, Andrea ^a   Cellini, Elena ^a   Bracco, Laura ^a   Sorbi, Sandro ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Alzheimer's disease; Apolipoprotein E; Brain derived neurotrophic factor; Polymorphism

Indexed keywords

APOLIPOPROTEIN E; BRAIN DERIVED NEUROTROPHIC FACTOR;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; COGNITION; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; MENTAL DISEASE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHI-SQUARE DISTRIBUTION; COGNITION; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RNA; VARIATION (GENETICS);

EID: 4444364872     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.06.039     Document Type: Article

References (27)

1. Bagnoli S., Nacmias B., Tedde A., Guarnieri B.M., Cellini E., Petruzzi C., Bartoli A., Ortenzi L., Sorbi S. Brain derived neutrophic factor genetic variants are not susceptibility factors to Alzheimer's disease in Italy. Ann. Neurol. 55:2004;447-448
2. Bracco L., Amaducci L., Pedone D., Bino G., Lazzaro M.P., Carella F., D'Antona R., Gallato R., Denes G. Italian Multicentre Study on Dementia (SMID): a neuropsychological test battery for assessing Alzheimer's disease. J. Psychiatr. Res. 24:1990;213-226
3. Bracco L., Amaducci L. Italian Multicenter Study on Dementia: a protocol for data collection and clinical diagnosis of Alzheimer's disease. The SMID Group. Neuroepidemiology. 11:1992;39-45
4. Cacabelos R. The application of functional genomics to Alzheimer's disease. Pharmacogenomics. 4:2003;597-621
5. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923
6. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., Zaitsev E., Gold B., Goldman D., Dean M., Lu B., Weinberger D.R. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell. 112:2003;257-269
7. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., van Duijn C.M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta. Analysis Consortium. JAMA. 278:1997;1349-1356
8. Gabrieli J.D., Preston A.R. Visualizing genetic influences on human brain functions. Cell. 112:2003;144-145
9. Giovagnoli A.R., Del Pesce M., Mascheroni S., Simoncelli M., Laiacona M., Capitani E. Trail making test: normative values from 287 normal adult controls. Ital. J. Neurol. Sci. 17:1996;305-309
10. Hanson I.M., Seawright A., van Heyningen V. The human BDNF gene maps between FSHB and HVBS1 at the boundary of 11p13-p14. Genomics. 13:1992;1331-1333
11. Hariri A.R., Goldberg T.E., Mattay V.S., Kolachana B.S., Callicott J.H., Egan M.F., Weinberger D.R. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J. Neurosci. 23:2003;6690-6694
12. Lu B., Gottschalk W. Modulation of hippocampal synaptic transmission and plasticity by neurotrophins. Prog. Brain Res. 128:2000;231-241
13. Maisonpierre P.C., Le Beau M.M., Espinosa R., Ip N.Y., Belluscio L., de la Monte S.M., Squinto S., Furth M.E., Yancopoulos G.D. Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations. Genomics. 10:1991;558-568
14. Marx J. Neuroscience. Minor variation in growth-factor gene impairs human memory. Science. 299:2003;639-640
15. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944
16. Mesulam M.M. Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles. Neuron. 24:1999;521-529
17. Murer M.G., Yan Q., Raisman-Vozari R. Brain-derived neurotrophic factor in the control human brain. Prog. Neurobiol. 63:2001;71-124
18. Nilsson L.G., Nyberg L., Backman L. Genetic variation in memory functioning. Neurosci. Biobehav. Rev. 26:2002;841-848
19. Poo M.M. Neurotrophins as synaptic modulators. Nat. Rev. Neurosci. 2:2001;24-32
20. Parasuraman R., Greenwood P.M., Sunderland T. The apolipoprotein E gene, attention, and brain function. Neuropsychology. 16:2002;254-274
21. Riemenschneider M., Schwarz S., Wagenpfeil S., Diehl J., Muller U., Forstl H., Kurz A. A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E epsilon4 allele. Mol. Psychiatry. 7:2002;782-785
22. Sorbi S., Nacmias B., Forleo P., Latorraca S., Gobbini I., Bracco L., Piacentini S., Amaducci L. ApoE allele frequencies in Italian sporadic and familial Alzheimer's disease. Neurosi. Lett. 177:1994;100-4102
23. Smith G.E., Bohac D.L., Waring S.C., Kokmen E., Tangalos E.G., Ivnik R.J., Petersen R.C. Alzheimer's disease but not in healthy control subjects. Neurology. 50:1998;355-362
24. Strittmatter W.J., Roses A.D. Apolipoprotein E and Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 92:1995;4725-4727
25. Ventriglia M., Bocchio Chiavetto L., Benussi L., Binetti G., Zanetti O., Riva M.A., Pennarelli M. Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease. Mol. Psychiatry. 7:2002;136-137
26. Wilson R.S., Schneider J.A., Barnes L.L., Beckett L.A., Aggarwal N.T., Cochran E.J., Berry-Kravis E., Bach J., Fox J.H., Evans D.A., Bennett D.A. The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period. Arch. Neurol. 59:2002;1154-1160
27. Kim K.W., Jhoo J.H., Lee J.H., Lee D.Y., Lee K.U., Youn J.C., Youn J.Y., Woo J.I. The domain-specific, stage-limited impact of the Apolipoprotein E epsilon-4 allele on cognitive functions in Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 13:2002;125-129